AI-generated summary
This structured narrative review examined photobiomodulation therapy for salivary dysfunction after head and neck radiotherapy, drawing on 42 publications. The authors report that PBMT may improve salivary flow in some settings, but patient-reported xerostomia benefits were inconsistent, and a 2026 meta-analysis found very-low-certainty evidence. They conclude that biomarker- or AI-guided precision PBMT remains unvalidated.
- Studies included
- 42
- Who or what was studied
- Patients with radiation-induced xerostomia or hyposalivation following radiotherapy for head and neck cancer
- Limits stated in the abstract
- The abstract notes heterogeneous and incompletely reported protocols, very-low-certainty evidence, and that no biomarker or AI model is validated to predict PBMT benefit.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Biomarker, Dosimetry, Meta-analysis, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.